Physician
The Pediatric Group, LLP
The Pediatric Group, LLP was paid $7.73M by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoTHE PEDIATRIC GROUP, LLP
DAVIDSONVILLE, MD 21035
DAVIDSONVILLE, MD 21035
33aNPI1598779886assigned 07/29/2006
33bProvider typePediatrics Physician
28Total paid$7.73M
24GClaims162,957
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#11 of 306
Median peer was paid$206K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 307 | $8K | |
| 2019 | 258 | $9K | |
| 2020 | 28,869 | $1.32M | |
| 2021 | 32,142 | $1.44M | |
| 2022 | 33,676 | $1.70M | |
| 2023 | 34,017 | $1.68M | |
| 2024incomplete | 33,688 | $1.57M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 24,951 | 21,792 | $2.07M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 18,091 | 15,887 | $2.05M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.7% | 6,233 | 5,033 | $598K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.0% | 5,136 | 4,782 | $541K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.1% | 4,459 | 4,247 | $473K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.1% | 2,472 | 2,088 | $394K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.1% | 2,801 | 2,592 | $316K |
| 99460 | 2.9% | 2,410 | 2,266 | $220K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.0% | 15,559 | 14,419 | $154K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.7% | 1,320 | 1,225 | $135K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,775 | 1,607 | $76K |
| 90686 | <1% | 3,086 | 2,757 | $67K |
46 more codes
| 99477 | <1% | 176 | $55K | |
| 87428 | <1% | 2,113 | $54K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 757 | $51K |
| 90670 | <1% | 2,163 | $50K | |
| 92551 | <1% | 5,125 | $47K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,946 | $45K |
| 90698 | <1% | 1,836 | $41K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,247 | $40K |
| 96127 | <1% | 5,360 | $27K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,348 | $26K |
| D1206 | Topical application of fluoride varnish | <1% | 884 | $21K |
| 99173 | <1% | 6,754 | $17K | |
| 90688 | <1% | 745 | $16K | |
| 90680 | <1% | 690 | $15K | |
| 99177 | <1% | 2,919 | $14K | |
| 87070 | <1% | 2,021 | $11K | |
| 96161 | <1% | 3,813 | $10K | |
| 94760 | <1% | 10,340 | $9K | |
| 90656 | <1% | 404 | $9K | |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 75 | $7K |
| 90633 | <1% | 337 | $7K | |
| 80061 | Lipid panel | <1% | 636 | $7K |
| 90710 | <1% | 261 | $6K | |
| 90651 | <1% | 251 | $5K | |
| 87807 | <1% | 510 | $5K | |
| 90744 | <1% | 231 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 94 | $4K |
| 90677 | <1% | 158 | $4K | |
| 90734 | <1% | 164 | $4K | |
| 90619 | <1% | 121 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,387 | $3K |
| 90697 | <1% | 127 | $2K | |
| 99463 | <1% | 14 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 14 | $2K |
| 99000 | <1% | 8,716 | $1K | |
| 90715 | <1% | 47 | $1K | |
| 99462 | <1% | 15 | $633.15 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 50 | $542.76 |
| 83655 | <1% | 43 | $411.97 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 40 | $353.52 |
| 90621 | <1% | 16 | $302.64 | |
| 96160 | <1% | 127 | $272.53 | |
| 81002 | <1% | 52 | $115.21 | |
| 36416 | <1% | 1,228 | $48.00 | |
| J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | <1% | 15 | $0.29 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,294 | $0.05 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRAW, ROBERT (PRESIDENT)
Parent organizationTHE PEDIATRIC GROUP, LLP
| Provider | Location | Paid |
|---|---|---|
| Harcart Health Holdings, LLC | Rockville, MD | $5.41M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.